Shockwave Medical, Inc. (SWAV)
May 31, 2024 - SWAV was delisted (reason: acquired by JNJ)
334.75
0.00 (0.00%)
Inactive · Last trade price
on May 30, 2024
ShockWave Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2017 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2017 - 2018 |
| Revenue | 787.97 | 730.23 | 489.73 | 237.15 | 67.79 | 42.93 | Upgrade
|
| Revenue Growth (YoY) | 41.42% | 49.11% | 106.51% | 249.83% | 57.92% | 250.05% | Upgrade
|
| Cost of Revenue | 102.53 | 95.39 | 65 | 41.44 | 20.99 | 17.16 | Upgrade
|
| Gross Profit | 685.44 | 634.84 | 424.74 | 195.71 | 46.8 | 25.77 | Upgrade
|
| Selling, General & Admin | 353.71 | 323.2 | 218.92 | 146.04 | 75.54 | 44.75 | Upgrade
|
| Research & Development | 163.14 | 145.65 | 81.68 | 50.54 | 36.93 | 32.85 | Upgrade
|
| Operating Expenses | 516.85 | 468.85 | 300.6 | 196.58 | 112.46 | 77.61 | Upgrade
|
| Operating Income | 168.59 | 165.99 | 124.13 | -0.87 | -65.66 | -51.84 | Upgrade
|
| Interest Expense | -9.21 | -6.91 | -1.89 | -1.1 | -1.21 | -0.94 | Upgrade
|
| Interest & Investment Income | 10.58 | - | - | - | - | - | Upgrade
|
| Earnings From Equity Investments | -0.33 | -1.87 | -2.48 | -6.29 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 20.82 | 23.96 | 1.06 | -0.58 | 1.26 | 1.74 | Upgrade
|
| EBT Excluding Unusual Items | 190.44 | 181.18 | 120.83 | -8.84 | -65.62 | -51.05 | Upgrade
|
| Merger & Restructuring Charges | -6.9 | -6.9 | - | - | - | - | Upgrade
|
| Pretax Income | 183.54 | 174.28 | 120.83 | -8.84 | -65.62 | -51.05 | Upgrade
|
| Income Tax Expense | 20.04 | 27 | -95.17 | 0.3 | 0.08 | 0.06 | Upgrade
|
| Net Income | 163.5 | 147.28 | 216 | -9.14 | -65.7 | -51.11 | Upgrade
|
| Net Income to Common | 163.5 | 147.28 | 216 | -9.14 | -65.7 | -51.11 | Upgrade
|
| Net Income Growth | -32.05% | -31.81% | - | - | - | - | Upgrade
|
| Shares Outstanding (Basic) | 37 | 37 | 36 | 35 | 33 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 38 | 38 | 38 | 35 | 33 | 24 | Upgrade
|
| Shares Change (YoY) | 0.95% | 0.86% | 7.93% | 6.08% | 38.42% | 1260.47% | Upgrade
|
| EPS (Basic) | 4.43 | 4.01 | 6.02 | -0.26 | -1.99 | -2.14 | Upgrade
|
| EPS (Diluted) | 4.26 | 3.85 | 5.70 | -0.26 | -1.99 | -2.14 | Upgrade
|
| EPS Growth | -32.67% | -32.46% | - | - | - | - | Upgrade
|
| Free Cash Flow | 166.14 | 165.46 | 92.61 | 2.6 | -82.7 | -51.92 | Upgrade
|
| Free Cash Flow Per Share | 4.33 | 4.33 | 2.44 | 0.07 | -2.50 | -2.17 | Upgrade
|
| Gross Margin | 86.99% | 86.94% | 86.73% | 82.53% | 69.03% | 60.03% | Upgrade
|
| Operating Margin | 21.39% | 22.73% | 25.35% | -0.37% | -96.86% | -120.76% | Upgrade
|
| Profit Margin | 20.75% | 20.17% | 44.10% | -3.85% | -96.92% | -119.06% | Upgrade
|
| Free Cash Flow Margin | 21.08% | 22.66% | 18.91% | 1.09% | -122.00% | -120.96% | Upgrade
|
| EBITDA | 180.35 | 176.35 | 128.99 | 2.71 | -63.8 | -50.5 | Upgrade
|
| EBITDA Margin | 22.89% | 24.15% | 26.34% | 1.14% | -94.12% | -117.65% | Upgrade
|
| D&A For EBITDA | 11.76 | 10.36 | 4.86 | 3.58 | 1.86 | 1.34 | Upgrade
|
| EBIT | 168.59 | 165.99 | 124.13 | -0.87 | -65.66 | -51.84 | Upgrade
|
| EBIT Margin | 21.39% | 22.73% | 25.35% | -0.37% | -96.86% | -120.76% | Upgrade
|
| Effective Tax Rate | 10.92% | 15.49% | - | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.